Pharmaceuticals & Healthcare Market Reports

robertjackson5249 un-follow

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets.


0 likes : 12 views : November 14, 2017

In this report, the EMEA High Potency Active Pharmaceutical Ingredients (HPAPI) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

https://www.radiantinsights.com/research/emea-europe-middle-east-and-africa-high-potency-active-pharmaceutical-ingredients-hpapi-industry-2017/request-sample

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of High Potency Active Pharmaceutical Ingredients (HPAPI) for these regions, from 2012 to 2022 (forecast)

  • Europe: Germany, France, UK, Russia, Italy and Benelux;
  • Middle East: Saudi Arabia, Israel, UAE and Iran;
  • Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA High Potency Active Pharmaceutical Ingredients (HPAPI) market competition by top manufacturers/players, with High Potency Active Pharmaceutical Ingredients (HPAPI) sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

  • Eli Lilly and Company
  • Novartis International AG
  • Bristol-Myers Squibb Company
  • Roche Diagnostics Limited
  • Sanofi Aventis
  • Hospira, Inc.
  • BASF AG
  • Covidien Plc
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • Sigma Aldrich Corporation
  • Bayer AG
  • Carbogen Amcis AG
  • Lonza
  • Teva Pharmaceuticals Industries Ltd.

https://www.radiantinsights.com/research/emea-europe-middle-east-and-africa-high-potency-active-pharmaceutical-ingredients-hpapi-industry-2017

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

  • Synthetic
  • Biotech

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of High Potency Active Pharmaceutical Ingredients (HPAPI) for each application, including

  • Oncology
  • Hormonal
  • Glaucoma
  • Others

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:

Michelle Thoras

201 Spear Street 1100,

Suite 3036, San Francisco,

CA 94105, United States

Tel: 1-415-349-0054

Toll Free: 1-888-928-9744

Mail: sales@radiantinsights.com

You need to sign in to leave comments. If you are not a member, you can join Doccler for free.